Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
federal funding
Research
NIH grants generated a 250% return on $36.6B investment in 2025
Funding delays and NIH turmoil preceded a total economic impact reduction of $430 million compared to 2024.
Will Maddox
Mar 11, 2026 11:11am
ARPA-H launches $158M effort for first lymphatic meds
Mar 4, 2026 8:55am
ARPA-H designates up to $144M for anti-aging medical research
Feb 25, 2026 11:55am
ARPA-H director eyes future beyond vaccines
Jan 20, 2026 5:00am
Flagship CEO warns Trump admin is 'undoing' scientific method
Jan 12, 2026 5:00am
Fired NIAID director sues health officials, calls ouster illegal
Dec 17, 2025 1:22pm
